KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Non Operating Investment Income: 2009-2013

Historic Non Operating Investment Income for Novavax (NVAX) over the last 5 years, with Dec 2013 value amounting to $267,000.

  • Novavax's Non Operating Investment Income was N/A to $502,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $101,000, marking a year-over-year change of. This contributed to the annual value of $267,000 for FY2013, which is 164.36% up from last year.
  • Novavax's Non Operating Investment Income amounted to $267,000 in FY2013, which was up 164.36% from $101,000 recorded in FY2012.
  • Novavax's 5-year Non Operating Investment Income high stood at $2.5 million for FY2011, and its period low was -$2.0 million during FY2009.
  • Over the past 3 years, Novavax's median Non Operating Investment Income value was $267,000 (recorded in 2013), while the average stood at $947,333.
  • Its Non Operating Investment Income has fluctuated over the past 5 years, first surged by 184.74% in 2010, then crashed by 95.92% in 2012.
  • Over the past 5 years, Novavax's Non Operating Investment Income (Yearly) stood at -$2.0 million in 2009, then surged by 184.74% to $1.7 million in 2010, then surged by 48.06% to $2.5 million in 2011, then crashed by 95.92% to $101,000 in 2012, then soared by 164.36% to $267,000 in 2013.